RRAS2 and carcinoma: We have identified breast cancer as the first human carcinoma that could emerge from the overexpression of wild-type RRAS2. Recently, we published that overexpression of wild-type RRAS2 is also responsible for the development of chronic lymphocytic leukemia (CLL) [19].